Palliative care
PRINCIPAL INVESTIGATORS
- Jesus Gonzalez Barboteo
CLINICAL RESEARCHERS
- Silvia Llorens Torrome
- Sonia Gala Serrano Bermúdez
- Joaquim Julià Torras
COLLABORATORS
- Dolors Mateo Ortega
SCIENTIFIC SUPPORT
- Cristina Lasmarias Martínez
MANAGEMENT SUPPORT
- Sara Ela Aguilar
- Jose Armando Espinosa Rojas
Cancer
Epidemiology, Public Health, Cancer Prevention and Palliative Care
Scientific production
9
PAPERS
2 PUBLICATIONS IN FIRST DECILE
3 PUBLICATIONS IN FIRST QUARTILE
Selected publications
- Quiñoa-Salanova C, Porta-Sales J, Monforte-Royo C, Edo-Gual M . The experiences and needs of primary family caregivers of patients with multiple myeloma: A qualitative analysis.. PALLIATIVE MEDICINE. 10.1177/0269216319830017
- Porta-Sales J, Crespo I, Monforte-Royo C, Marín M, Abenia-Chavarria S, Balaguer A . The clinical evaluation of the wish to hasten death is not upsetting for advanced cancer patients: A cross-sectional study.. PALLIATIVE MEDICINE. 10.1177/0269216318824526
- Gómez-Miragaya J, Morán S, Calleja-Cervantes ME, Collado-Sole A, Paré L, Gómez A, Serra V, Dobrolecki LE, Lewis MT, Diaz-Lagares A, Eroles P, Prat A, Esteller M, González-Suárez E . The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models.. MOLECULAR CANCER RESEARCH. 10.1158/1541-7786.MCR-19-0040
- Tripodoro V.A., Llanos V., DE LELLIS S., Salazar Güemes C., DE SIMONE G.G., Gómez-Batiste X.. PROGNOSTIC FACTORS IN CANCER PATIENTS WITH PALLIATIVE NEEDS IDENTIFIED BY THE NECPAL CCOMS-ICO (c) TOOL. MEDICINA.
Research highlights
PROJECTS
1 ongoing project
5 ongoing clinical trials
Selected projects
- Estudi observacional prospectiu de tractament adaptat al risc de la LMA i les SMD a Catalunya (27/3/2017 – 31/12/2019) PI: ARNAN SANGERMAN, MONTSERRAT. Funder: DEPARTAMENT SALUT (PR).
- Evaluación de la calidad de vida de pacientes con estreñimiento inducido por opioides en tratamiento con Naloxegol: estudio de un año de seguimiento. Estudio Kyonal. (24/10/2017 – 24/10/2019) PI: SERRANO BERMUDEZ, SONIA GALA. Funder ref.: KYO-NAL-2017-01.
- Evaluación de la calidad de vida y satisfacción del paciente con dolor irruptivo oncológico asociado a la enfermedad metastásica ósea en unidades de dolor, oncología radioterápica y cuidados paliativos (9/10/2017 – 1/4/2022) PI: SERRANO BERMUDEZ, SONIA GALA. Funder ref.: Q-DIOSEO.
- A phase 3 multi-center, randomized, double-blind, placebo-controlled trial of the flt3 inhibitor Gilteritinib (ASP2215) administered as maintenance therapy following induction/consolidation therapy for subjects with FLT3/ITD AMB in first complete remission (20/2/2017 – 31/12/2026) PI: ARNAN SANGERMAN, MONTSERRAT. Funder ref.: 2215-CL-0302.
- A phase 3, double-blind, placebo-controlled study of Quizartinib (AC220) administered in combination with induction and consolidation chemotherapy, and administered as maintenance therapy in subjects 18 to 75 years old with newly diagnosed flt3-itd (+) acute myeloid leukemia (Quantum First) (26/1/2017 – 30/12/2026) PI: ARNAN SANGERMAN, MONTSERRAT. Funder ref.: AC220-A-U302.
- Estudio postautorización de tipo observacional definición de consenso de disnea irruptiva en pacientes oncológicos: estudio Delphi de expertos españoles (29/12/2016 – 29/12/2022) PI: JULIÀ TORRES, JOAQUIM. Funder ref.: INSPIRA.